These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7910064)

  • 21. Extensive prolongation of rat renal allograft survival following donor or nonspecific transfusions and concomitant immunosuppressant.
    Martin DC; Hewitt CW; Black KS; Dowdy SF; Quintero CS; Reyes M
    Transplantation; 1987 Jun; 43(6):790-4. PubMed ID: 3296345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of cyclosporin immunosuppression on serum magnesium and its fractional excretion in renal transplant recipients.
    Nawaz SH; Zafar MN; Naqvi SA; Rizvi SA
    J Pak Med Assoc; 2005 Mar; 55(3):98-100. PubMed ID: 15852743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine blood monitoring after heart transplantation: a prospective comparison of monoclonal and polyclonal radioimmunoassays.
    Bourge RC; Kirklin JK; Ketchum C; Naftel DC; Mason DA; Siegel AL; Scott JW; White-Williams C
    J Heart Lung Transplant; 1992; 11(3 Pt 1):522-9. PubMed ID: 1610859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine increases the oxidizability of low-density lipoproteins in renal transplant recipients.
    Apanay DC; Neylan JF; Ragab MS; Sgoutas DS
    Transplantation; 1994 Sep; 58(6):663-9. PubMed ID: 7524202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypomagnesemia in renal transplant patients: improvement over time and association with hypertension and cyclosporine levels.
    Ramos EL; Barri YM; Kubilis P; Peterson JC; Pfaff WW; Howard RJ; Parris CJ; Patton PR; Karlix JL
    Clin Transplant; 1995 Jun; 9(3 Pt 1):185-9. PubMed ID: 7549058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considerations for monitoring cyclosporine in transplant recipients.
    Napoli KL; Kahan BD
    Clin Lab Med; 1991 Sep; 11(3):671-91. PubMed ID: 1934970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients.
    Falck P; Asberg A; Guldseth H; Bremer S; Akhlaghi F; Reubsaet JL; Pfeffer P; Hartmann A; Midtvedt K
    Transplantation; 2008 Jan; 85(2):179-84. PubMed ID: 18212621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
    Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
    Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cyclosporin interactions in kidney transplants].
    Díaz Couselo FA; Porato F; Turín M; Etchegoyen FP; Diez RA
    Medicina (B Aires); 1992; 52(4):296-302. PubMed ID: 1340878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of variables contributing to cyclosporine distribution in blood.
    Broin SO; Clarke E; McCann S
    Ir J Med Sci; 1990; 159(9-12):269-71. PubMed ID: 2094690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The concentration of cyclosporine metabolites is significantly lower in kidney transplant recipients with diabetes mellitus.
    Akhlaghi F; Dostalek M; Falck P; Mendonza AE; Amundsen R; Gohh RY; Asberg A
    Ther Drug Monit; 2012 Feb; 34(1):38-45. PubMed ID: 22210099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between cyclosporine A and adenosine in kidney transplant recipients.
    Guieu R; Dussol B; Devaux C; Sampol J; Brunet P; Rochat H; Bechis G; Berland YF
    Kidney Int; 1998 Jan; 53(1):200-4. PubMed ID: 9453019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of four different cyclosporine immunoassays in heart and kidney transplant recipients.
    Hesse CJ; Baan CC; Daane R; Stolk BJ; Jutte NH; Hendriks GF; Weimar W
    Ther Drug Monit; 1990 Nov; 12(6):547-53. PubMed ID: 2275000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients.
    Blackhall ML; Fassett RG; Sharman JE; Geraghty DP; Coombes JS
    Nephrol Dial Transplant; 2005 Sep; 20(9):1970-5. PubMed ID: 15998657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the determination of cyclosporin-A in blood samples collected on filter paper and by the ordinary technique].
    Azevedo LS; Manrique R; Sabbaga E
    Rev Assoc Med Bras (1992); 1995; 41(3):183-6. PubMed ID: 8574226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine monitoring in peripheral blood mononuclear cells: feasibility and interest. A prospective study on 20 renal transplant recipients.
    Lepage JM; Lelong-Boulouard V; Lecouf A; Debruyne D; Hurault de Ligny B; Coquerel A
    Transplant Proc; 2007 Dec; 39(10):3109-10. PubMed ID: 18089333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression.
    Sommerer C; Giese T; Schmidt J; Meuer S; Zeier M
    Transplantation; 2008 Jan; 85(1):15-21. PubMed ID: 18192906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.